A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti

PLoS Neglected Tropical Diseases

Volumn 4, Issue 3, 2010, Pages

  Boyd, Alexis ^a   Won, Kimberly Y ^a   McClintock, Shannon K ^a   Donovan, Catherine V ^b   Laney, Sandra J ^c   Williams, Steven A ^c   Pilotte, Nils ^c   Streit, Thomas G ^b   Beau De Rochars, Madsen V E ^d   Lammie, Patrick J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

^c SMITH COLLEGE   (United States)

^d Hopital Ste Croix ^*  (Haïti)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; HELMINTH ANTIBODY; HELMINTH DNA; ANTIFILARIAL AGENT; PARASITE ANTIGEN;

ADULT; ANTIBODY DETECTION; ARTICLE; CULEX QUINQUEFASCIATUS; DISEASE TRANSMISSION; FEMALE; HAITI; HEALTH SURVEY; HUMAN; IMMUNOASSAY; INFECTION RISK; LYMPHATIC FILARIASIS; MAJOR CLINICAL STUDY; MALE; MICROFILARIASIS; NONHUMAN; PATIENT COMPLIANCE; POPULATION MIGRATION; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; WUCHERERIA BANCROFTI; ADOLESCENT; AGED; BLOOD; CHILD; CLUSTER ANALYSIS; ENDEMIC DISEASE; MIDDLE AGED; PRESCHOOL CHILD; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; ELEPHANTIASIS, FILARIAL; ENDEMIC DISEASES; FEMALE; FILARICIDES; HAITI; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; YOUNG ADULT;

EID: 77950404213     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000640     Document Type: Article

References (36)

1. (2008) Global programme to eliminate lymphatic filariasis. Weekly Epidemiologic Report 83: 333-341.
2. Ottesen EA, Hooper PJ, Bradley M, Biswas G (2008) The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Neg Trop Dis 2: e317.
3. Ottesen EA, Duke BO, Karam M, Behbehani K (1997) Strategies and tools for the control/elimination of lymphatic filariasis. Bulletin of the World Health Organization 75: 491-503.
4. WHO (2000) Preparing and Implementing a National Plan to Eliminate Lymphatic Filariasis. Geneva: World Health Organization.
5. Beau de Rochars MVE, Milord MD, St Jean Y, Désormeaux AM, Dorvil JJ, et al. (2004) Geographic distribution of lymphatic filariasis in Haiti. Am J Trop Med Hyg 71: 598-601.
6. de Rochars MB, Kanjilal S, Direny AN, Radday J, Lafontant JG, et al. (2005) The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration. Amer J Trop Med Hyg 73: 888-894.
7. Grady CA, de Rochars MB, Direny AN, Orelus JN, Wendt J, et al. (2007) Endpoints for lymphatic filariasis programs. Emerg Infect Dis 13: 608-610.
8. WHO (2005) Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level. Geneva: World Health Organization.
9. Vanden Eng JL, Wolkon A, Frolov AS, Terlouw DJ, Eliades MJ, et al. (2007) Use of handheld computers with global positioning systems for probability sampling and data entry in household surveys. Amer J Trop Med Hyg 77: 393-399.
10. Weil GJ, Lammie PJ, Weiss N (1997) The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol Today 13: 401-404.
11. Lammie PJ, Weil G, Noordin R, Kaliraj P, Steel C, et al. (2004) Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial. Filaria J 3: 9.
12. Laney SJ, Buttaro CJ, Visconti S, Pilotte N, Ramzy RMR, et al. (2008) A reverse transcriptase-PCR assay for detecting filarial infective larvae in mosquitoes. PLoS Negl Trop Dis 2: e251.
13. Plichart C, Sechan Y, Davies N, Legrand A-M (2006) PCR and dissection as tools to monitor filarial infection of Aedes polynesiensis mosquitoes in French Polynesia. Filaria J 5: 2.
14. Plichart C, Laney S, Sechan Y, Davies N, Legrand A-M (2007) Correction: PCR and dissection as tools to monitor filarial infection of Aedes polynesiensis mosquitoes in French Polynesia. Filaria Journal 6: 5.
15. Rao RU, Atkinson LJ, Ramzy RMR, Helmy H, Farid HA, et al. (2006) A real-time PCR-based assay for detection of Wuchereria bancrofti DNA in blood and mosquitoes. Amer J Trop Med Hyg 74: 826-832.
16. Katholi CR, Toé L, Merriweather A, Unnasch TR (1995) Determining the prevalence of Onchocerca volvulus infection in vector populations by polymerase chain reaction screening of pools of black flies. J Infect Dis 172: 1414-1417.
17. Cuzick J, Edwards R (1990) Spatial Clustering for Inhomogeneous Populations. J R Stat Soc Series B-Method 52: 73-104.
18. Simes RJ (1986) An improved bonferroni procedure for multiple tests of significance. Biometrika 73: 751-754.
19. Ottesen EA (2000) The global programme to eliminate lymphatic filariasis. Trop Med Int Health 5: 591-594.
20. Mathieu E, Direny AN, de Rochars MB, Streit TG, Addiss DG, et al. (2006) Participation in three consecutive mass drug administrations in Leogane, Haiti. Trop Med Int Health 11: 862-868.
21. Talbot JT, Viall A, Direny A, de Rochars MB, Addiss D, et al. (2008) Predictors of compliance in mass drug administration for the treatment and prevention of lymphatic filariasis in Leogane, Haiti. Amer J Trop Med Hyg 78: 283-288.
22. El-Setouhy M, Abd Elaziz KM, Helmy H, Farid HA, Kamal HA, et al. (2007) The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt. Amer J Trop Med Hyg 77: 1069-1073.
23. Ramaiah KD, Das PK, Appavoo NC, Ramu K, Augustin DJ, et al. (2000) A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects. Tropical Med Int Health 5: 842-847.
24. Ramaiah KD, Vijay Kumar KN, Chandrakala AV, Augustin DJ, Appavoo NC, et al. (2001) Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India. Tropical Med Int Health 6: 1062-1069.
25. Vanamail P, Ramaiah KD, Subramanian S, Pani SP, Yuvaraj J, et al. (2005) Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India. Ann Trop Med Parasitol 99: 237-242.
26. Babu BV, Mishra S (2008) Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance. Trans R Soc Trop Med Hyg 102: 1207-1213.
27. Amarillo MLE, Belizario VY, Sadiang-Abay JT, Sison SAM, Dayag AMS (2008) Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines. Parasit Vectors 1: 14.
28. Weerasooriya MV, Yahathugoda CT, Wickramasinghe D, Gunawardena KN, Dharmadasa RA, et al. (2007) Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka. Filaria J 6: 11.
29. Mathieu E, Lammie PJ, Radday J, Beach MJ, Streit T, et al. (2004) Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti. Ann Trop Med Parasitol 98: 703-714.
30. Hochberg N, Michel MC, Lammie PJ, Mathieu E, Direny AN, et al. (2006) Symptoms reported after mass drug administration for lymphatic filariasis in Leogane, Haiti. Amer J Trop Med Hyg 75: 928-932.
31. Ramzy RM, Hafez ON, Gad AM, Faris R, Harb M, et al. (1994) Efficient assessment of filariasis endemicity by screening for filarial antigenaemia in a sentinel population. Trans R Soc Trop Med Hyg 88: 41-44.
32. Tisch DJ, Hazlett FE, Kastens W, Alpers MP, Bockarie MJ, et al. (2001) Ecologic and biologic determinants of filarial antigenemia in bancroftian filariasis in Papua New Guinea. J Infect Dis 184: 898-904.
33. Washington CH, Radday J, Streit TG, Boyd HA, Beach MJ, et al. (2004) Spatial clustering of filarial transmission before and after a mass drug administration in a setting of low infection prevalence. Filaria J 3: 3.
34. Das PK, Vanamail P (2008) Probability risk transmission matrix as a decision tool for assessing methods of transmission interruption of Wuchereria bancrofti infection. Epidemiol Infect 136: 520-524.
35. Michael E, Snow LC, Bockarie MJ (2009) Ecological meta-analysis of density-dependent processes in the transmission of lymphatic filariasis: survival of infected vectors. J Med Entomol 46: 873-880.
36. Won KY, Beau de Rochars M, Kyelem D, Streit TG, Lammie PJ (2009) Assessing the impact of a missed mass drug administration in Haiti. PLoS Negl Trop Dis 3: e443.